Vanguard Group’s Inhibrx, Inc. Common Stock INBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $65.1M | Sell |
|
|||||
|
2023
Q4 | $71.2M | Buy |
|
|||||
|
2023
Q3 | $32.8M | Buy |
|
|||||
|
2023
Q2 | $46M | Sell |
|
|||||
|
2023
Q1 | $33.5M | Buy |
|
|||||
|
2022
Q4 | $43.4M | Buy |
|
|||||
|
2022
Q3 | $26.3M | Buy |
|
|||||
|
2022
Q2 | $15.4M | Buy |
|
|||||
|
2022
Q1 | $27.1M | Buy |
|
|||||
|
2021
Q4 | $52.7M | Buy |
|
|||||
|
2021
Q3 | $22.6M | Buy |
|
|||||
|
2021
Q2 | $13.6M | Buy |
|
|||||
|
2021
Q1 | $7.76M | Buy |
|
|||||
|
2020
Q4 | $12.6M | Buy |
|
|||||
|
2020
Q3 | $540K | Buy |
|